tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GSK Stock Latest News

Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
The FlyTrump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
1d ago
DV
ES
GSK’s New Study on Bepirovirsen: A Potential Game-Changer for Hepatitis B Treatment?
PremiumCompany Announcements
GSK’s New Study on Bepirovirsen: A Potential Game-Changer for Hepatitis B Treatment?
2d ago
GSK
Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads
PremiumThe Fly
Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads
3d ago
DV
AZN
Omnicom, WPP under pressure after Trump moves to regulate pharma ads
PremiumThe Fly
Omnicom, WPP under pressure after Trump moves to regulate pharma ads
3d ago
AZN
BMY
Trump Trade: U.S. President signs new pharma order
PremiumThe Fly
Trump Trade: U.S. President signs new pharma order
3d ago
DV
AZN
Trump signs memorandum mandating pharma ads give more info on risks
PremiumThe FlyTrump signs memorandum mandating pharma ads give more info on risks
4d ago
AZN
BMY
GSK’s Latest Prostate Cancer Study: A Potential Game-Changer?
Premium
Company Announcements
GSK’s Latest Prostate Cancer Study: A Potential Game-Changer?
6d ago
GSK
GSK’s New Pneumococcal Vaccine Trial: A Potential Game-Changer for Investors
Premium
Company Announcements
GSK’s New Pneumococcal Vaccine Trial: A Potential Game-Changer for Investors
6d ago
GSK
Sell Rating for GlaxoSmithKline Due to Projected Earnings Decline and Competitive Pressures
PremiumRatings
Sell Rating for GlaxoSmithKline Due to Projected Earnings Decline and Competitive Pressures
9d ago
GSK
Why Is Wave Life Sciences Stock (WVE) Down 20% Today?
PremiumMarket News
Why Is Wave Life Sciences Stock (WVE) Down 20% Today?
10d ago
GSK
WVE
Florida surgeon general says state will eliminate vaccine mandates
PremiumThe Fly
Florida surgeon general says state will eliminate vaccine mandates
10d ago
GSK
PFE
GSK’s Promising Phase 3 Study on Belimumab for Lung Disease
PremiumCompany Announcements
GSK’s Promising Phase 3 Study on Belimumab for Lung Disease
10d ago
GSK
Perspective Therapeutics appoints Maya Martinez-Davis to board of directors
PremiumThe FlyPerspective Therapeutics appoints Maya Martinez-Davis to board of directors
10d ago
GSK
CATX
Cautious Outlook on GlaxoSmithKline: Hold Rating Amid Strategic Uncertainties and Future Catalysts
Premium
Ratings
Cautious Outlook on GlaxoSmithKline: Hold Rating Amid Strategic Uncertainties and Future Catalysts
12d ago
GSK
GSK treatment of autosomal dominant polycystic kidney disease gets orphan status
Premium
The Fly
GSK treatment of autosomal dominant polycystic kidney disease gets orphan status
15d ago
GSK
GSK Executes Share Buyback as Part of Capital Management Strategy
PremiumCompany Announcements
GSK Executes Share Buyback as Part of Capital Management Strategy
15d ago
6K
GSK
GSK’s gepotidacin approved by U.K. MHRA
PremiumThe Fly
GSK’s gepotidacin approved by U.K. MHRA
16d ago
GSK
GSK’s Promising Phase 3 Study on Multiple Myeloma Treatment: A Market Game Changer?
PremiumCompany Announcements
GSK’s Promising Phase 3 Study on Multiple Myeloma Treatment: A Market Game Changer?
17d ago
GSK
GSK’s Promising Phase 3 Study on Relapsed SCLC: A Potential Game Changer
PremiumCompany Announcements
GSK’s Promising Phase 3 Study on Relapsed SCLC: A Potential Game Changer
17d ago
GSK
Veeva highlights GSK Vault CRM go-live across Europe
PremiumThe FlyVeeva highlights GSK Vault CRM go-live across Europe
19d ago
GSK
VEEV
GSK Vault CRM rollout a ‘key milestone’ for Veeva, says Raymond James
Premium
The Fly
GSK Vault CRM rollout a ‘key milestone’ for Veeva, says Raymond James
19d ago
CRM
GSK
Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
Premium
The Fly
Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
29d ago
AMD
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >